144 related articles for article (PubMed ID: 30607795)
1. Application of new measures of nonlinearity to parameter estimation and simulations in individual pharmacokinetic analyses.
Khinkis L; Crotzer M
J Pharmacokinet Pharmacodyn; 2019 Feb; 46(1):43-52. PubMed ID: 30607795
[TBL] [Abstract][Full Text] [Related]
2. Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs.
Wolfsegger MJ; Jaki T
J Pharmacokinet Pharmacodyn; 2009 Oct; 36(5):479-94. PubMed ID: 19847629
[TBL] [Abstract][Full Text] [Related]
3. Comparison of robust criteria for D-optimal designs.
Foo LK; McGree J; Eccleston J; Duffull S
J Biopharm Stat; 2012; 22(6):1193-205. PubMed ID: 23075017
[TBL] [Abstract][Full Text] [Related]
4. Kinetic parameter estimation by numerical algorithms and multiple linear regression: application to pharmacokinetics.
Yeh KC; Kwan KC
J Pharm Sci; 1979 Sep; 68(9):1120-4. PubMed ID: 501533
[TBL] [Abstract][Full Text] [Related]
5. Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokinetics.
Dumont C; Chenel M; Mentré F
J Biopharm Stat; 2014; 24(3):471-92. PubMed ID: 24697342
[TBL] [Abstract][Full Text] [Related]
6. A simulation study of parameter estimation in the one and two compartment models.
Laskarzewski PM; Weiner DL; Ott L
J Pharmacokinet Biopharm; 1982 Jun; 10(3):317-34. PubMed ID: 7175702
[TBL] [Abstract][Full Text] [Related]
7. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
Knights J; Rohatagi S
J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
[TBL] [Abstract][Full Text] [Related]
8. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model.
Steimer JL; Mallet A; Golmard JL; Boisvieux JF
Drug Metab Rev; 1984; 15(1-2):265-92. PubMed ID: 6745083
[TBL] [Abstract][Full Text] [Related]
9. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the nonparametric estimation method in NONMEM VI.
Savic RM; Kjellsson MC; Karlsson MO
Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data.
Sheiner LB; Beal SL
J Pharmacokinet Biopharm; 1980 Dec; 8(6):553-71. PubMed ID: 7229908
[TBL] [Abstract][Full Text] [Related]
12. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
13. Computational problems of compartment models with Michaelis-Menten-type elimination.
Metzler CM; Tong DD
J Pharm Sci; 1981 Jul; 70(7):733-7. PubMed ID: 7264916
[TBL] [Abstract][Full Text] [Related]
14. Impact of saturable distribution in compartmental PK models: dynamics and practical use.
Peletier LA; de Winter W
J Pharmacokinet Pharmacodyn; 2017 Feb; 44(1):1-16. PubMed ID: 28050672
[TBL] [Abstract][Full Text] [Related]
15. Two bootstrapping routines for obtaining imprecision estimates for nonparametric parameter distributions in nonlinear mixed effects models.
Baverel PG; Savic RM; Karlsson MO
J Pharmacokinet Pharmacodyn; 2011 Feb; 38(1):63-82. PubMed ID: 21076858
[TBL] [Abstract][Full Text] [Related]
16. Methods of robust design of nonlinear models with an application to pharmacokinetics.
Foo LK; Duffull S
J Biopharm Stat; 2010 Jul; 20(4):886-902. PubMed ID: 20496212
[TBL] [Abstract][Full Text] [Related]
17. A point estimator for the time course of drug release.
Koehne-Voss S; Pigeot I
Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
[TBL] [Abstract][Full Text] [Related]
18. [Comparison study of model evaluation methods: normalized prediction distribution errors vs. visual predictive check].
Ren YP; Deng CH; Wang XP; Zhou TY; Lu W
Yao Xue Xue Bao; 2011 Sep; 46(9):1123-31. PubMed ID: 22121786
[TBL] [Abstract][Full Text] [Related]
19. The deterministic identifiability of nonlinear pharmacokinetic models.
Godfrey KR; Fitch WR
J Pharmacokinet Biopharm; 1984 Apr; 12(2):177-91. PubMed ID: 6491900
[TBL] [Abstract][Full Text] [Related]
20. A general method to determine sampling windows for nonlinear mixed effects models with an application to population pharmacokinetic studies.
Foo LK; McGree J; Duffull S
Pharm Stat; 2012; 11(4):325-33. PubMed ID: 22411749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
